Application of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorChina-Japan Friendship Hospital
About this trial
The goal of this clinical study is to learn about the diagnostic effectiveness, safety, and influencing factors of transbronchial cryobiopsy（TBLC）in progressive pulmonary fibrosis. The main question it aims to answer are: • Determine the prognosis, health economics, and therapeutic strategy changes of patients with TBLC retrograde malleable pulmonary fibrosis. Participants will be randomly divided into two groups, and received TBLB or TBLC.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Transbronchial Cryobiopsy，TBLC
Procedure/SurgeryTransbronchial lung cryobiopsy (TBLC) is a novel technique that has proved its diagnostic value in various diffuse parenchymal lung diseases
Transbronchial Lung Biopsy，TBLB
Procedure/SurgeryTransbronchial lung biopsy (TBLB) is a relatively safe technique routinely employed by pulmonologists for the diagnosis of diffuse parenchymal lung disease
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: Transbronchial Cryobiopsy (TBLC)Experimental treatment 1 intervention
Group B: Transbronchial Lung Biopsy (TBLB)Active comparator 1 intervention
Trial outcomes
Primary outcomes
1
the diagnostic performance of transbronchial cryobiopsy（TBLC）
the sensitivity and specificity of transbronchial cryobiopsy（TBLC）in suspected progressive pulmonary fibrosis
Time frame
1 month after transbronchial cryobiopsySecondary outcomes
1
the safety of transbronchial cryobiopsy（TBLC)
The occurence of short-term procedure-related complications, including Bleeding, pneumothorax, death, etc
Time frame
7 days and 1 month after transbronchial cryobiopsySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov